Skip to main content
. 2020 Dec;12(12):7218–7226. doi: 10.21037/jtd-20-2131

Table 2. Evaluation of the tumors using HRCT and 3D CT in each group.

Variables Total (n=195) HL group (n=57) TL group (n=138) P value
Clinical T status, n (%) 0.033
   Tis 19 [10] 0 [0] 19 [14]
   T1mi 40 [21] 16 [28] 24 [17]
   T1a-T1c 136 [69] 41 [72] 95 [69]
HRCT findings
   Whole tumor size (cm) 0.579
    Range 0.5–4.4 0.6–4.1 0.5–3.9
    Mean ± SD 1.93±0.76 1.97±0.74 1.92±0.76
   Solid tumor size (cm) 0.045
    Range 0–3.0 0.3–2.6 0–3.0
    Mean ± SD 1.08±0.78 1.11±0.78 1.07±0.78
3D CT findings
   Whole tumor volume (mm3) 0.466
    Range 102.0–22,876.5 214.1–1,8981.2 102.0–2,2876.5
    Mean ± SD 2,975.0±3,426.7 2,994.8±3,450.0 2,966.8±3,426.7
   Solid tumor volume (mm3) 0.329
    Range 0–7,044 0.5–4,839.1 0–7,044
    Mean ± SD 1,026.0±1,364.5 779.3±1,358.0 1,127.9±1,361.3

HRCT, High-resolution computed tomography; 3D CT, three-dimensional computed tomography; SD, standard deviation; HL, Hazy lesion; TL, typical lesion.